The evolution of pharma and biopharma over the past 30 years has led to Ireland becoming a global leader, Gilead’s David Cadogan tells Pádraig Hoare.

Catch up on all the headlines this lunchtime...

HIV preventative care is a huge issue for activists. Gilead Sciences in Cork manufactures the drug Truveda. Caomhan Keane meets the head of commercial operations.

The threat of slowing demand and new competition in GlaxoSmithKline’s flagship HIV drug business has unnerved investors in the UK’s biggest drugmaker, sending its shares down 1.8%.

Located in Cork’s Carrigtwohill IDA Business Park is an investment property with an international flavour you don’t normally expect in the southern capital’s commercial market.

International groups representing doctors and patients have launched a fresh challenge to the patent on Gilead Sciences’ hepatitis C drug Sofosbuvir at the European Patent Office in order to increase access to the treatment.

Pfizer has clinched the purchase of US cancer drug company Medivation in a deal valued at about $14bn, (€12.4bn) adding blockbuster prostate cancer drug Xtandi to its portfolio.

London Mayor Boris Johnson is proposing a £10bn (€14bn) fund to encourage growth of emerging healthcare companies in the UK in an effort to catch up to biotechnology clusters in the US.

A potentially live-saving liver cancer drug that costs €560 per tablet will be made available to more than 100 seriously ill patients six months after doctors treating the disease asked the Government to fund it.

The Nasdaq had its worst day since 2011 as investors dumped biotechnology shares and other industries that have soared over the past year.

New signs of life in the manufacturing sector helped push the US stock market to a record high today.

A positive report on US consumer spending helped push most stocks higher for the first time in three days.

GlaxoSmithKline Plc has won US regulatory approval for a daily pill against the deadly HIV infection that was developed by ViiV Healthcare Ltd, its joint venture with two other drugmakers.

Successful Dragons Den contestant Sarah Nic Lochlainn of Aruna Sauces is among the nominees for this year’s Women Mean Business awards.

The US has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids.

Abbott Laboratories has reported earnings that beat analysts’ estimates and raised its 2012 forecast as sales jumped more than expected for its top product.

A new gel can block the Aids virus, halving a woman’s chances of getting HIV from an infected partner, US scientists say.

A biotechnology company has announced plans to create 30 new jobs in Cork.

CORK needs to establish an embassy in Dublin.

GILEAD Sciences yesterday announced that Gilead Sciences Limited, a wholly-owned Irish subsidiary, has completed its acquisition of Cork- based Nycomed Limited, formerly known as Altana Pharma Limited.